FdaApplication
NDA 204914
Identifiers
- fda_app_no: NDA204914
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABS |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE; ZIDOVUDINE | LAMIVUDINE; ZIDOVUDINE | 30MG;60MG | TABLET;ORAL SUSPENSION |
1 product